Abstract
99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.
Original language | English (US) |
---|---|
Pages (from-to) | 1079-1085 |
Number of pages | 7 |
Journal | IDrugs |
Volume | 6 |
Issue number | 11 |
State | Published - Nov 2003 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery